Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Go Ohira

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Patient with Recurrent Ulcerative Colitis-Associated Rectal Cancer Attaining a Complete Response with FOLFIRI plus Bevacizumab]Yasuhito Iseki, Kiyoshi Maeda, Masatsune Shibutani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[Clinical Outcome of the Patients with Anal Squamous Cell Carcinoma]Takuya Mori, Kiyoshi Maeda, Tatsunari Fukuoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2019
[Efficacy and Safety of Paclitaxel plus Ramucirumab Therapy for Unresectable or Recurrent Gastric Cancer]Gen Tsujio, Takahiro Toyokawa, Tatsunari Fukuoka, et al.
World Journal of Surgery|October 20, 2021
Prognostic Factors and Lymph Node Metastasis Patterns of Primary Duodenal CancerKohei Nishio, Kenjiro Kimura, Shimpei Eguchi, et al.
Clinical Journal of Gastroenterology|April 3, 2021
Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case reportShimpei Eguchi, Hiroji Shinkawa, Yasunori Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of Metastatic Lung Cancer from Colon Cancer with a Long Partial Response with Regorafenib Treatment]Yasuhito Iseki, Masakazu Yashiro, Masatsune Shibutani, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 28, 2020
Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for HepatolithiasisToru Miyazaki, Hiroji Shinkawa, Shigekazu Takemura, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Clinical Implication of Preoperative C-Reactive Protein/Albumin Ratio in Malignant Transformation of Intraductal Papillary Mucinous Neoplasm: A Propensity Score AnalysisHirotsugu Maruyama, Kojiro Tanoue, Yuki Ishikawa-Kakiya, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Two long-term survival cases of unresectable intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy and radiation therapy]Hisateru Komatsu, Akishige Kanazawa, Tadashi Tsukamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of radical resection for pancreatic head cancer with peritoneal dissemination treated with combination chemotherapy]Takayoshi Nakajima, Tadashi Tsukamoto, Akishige Kanazawa, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Patient with Recurrent Ulcerative Colitis-Associated Rectal Cancer Attaining a Complete Response with FOLFIRI plus Bevacizumab]Yasuhito Iseki, Kiyoshi Maeda, Masatsune Shibutani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[Clinical Outcome of the Patients with Anal Squamous Cell Carcinoma]Takuya Mori, Kiyoshi Maeda, Tatsunari Fukuoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2019
[Efficacy and Safety of Paclitaxel plus Ramucirumab Therapy for Unresectable or Recurrent Gastric Cancer]Gen Tsujio, Takahiro Toyokawa, Tatsunari Fukuoka, et al.
World Journal of Surgery|October 20, 2021
Prognostic Factors and Lymph Node Metastasis Patterns of Primary Duodenal CancerKohei Nishio, Kenjiro Kimura, Shimpei Eguchi, et al.
Clinical Journal of Gastroenterology|April 3, 2021
Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case reportShimpei Eguchi, Hiroji Shinkawa, Yasunori Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of Metastatic Lung Cancer from Colon Cancer with a Long Partial Response with Regorafenib Treatment]Yasuhito Iseki, Masakazu Yashiro, Masatsune Shibutani, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 28, 2020
Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for HepatolithiasisToru Miyazaki, Hiroji Shinkawa, Shigekazu Takemura, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Clinical Implication of Preoperative C-Reactive Protein/Albumin Ratio in Malignant Transformation of Intraductal Papillary Mucinous Neoplasm: A Propensity Score AnalysisHirotsugu Maruyama, Kojiro Tanoue, Yuki Ishikawa-Kakiya, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Two long-term survival cases of unresectable intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy and radiation therapy]Hisateru Komatsu, Akishige Kanazawa, Tadashi Tsukamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of radical resection for pancreatic head cancer with peritoneal dissemination treated with combination chemotherapy]Takayoshi Nakajima, Tadashi Tsukamoto, Akishige Kanazawa, et al.
Pageof 6